New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
April 17, 2013
10:16 EDTPIPPharmAthene says Army completed recombinant bioscavenger testing
PharmAthene announced that the U.S. Army Medical Research Institute for Chemical Defense has completed initial in vitro testing of the company's recombinant butyrylcholinesterase bioscavenger demonstrating that it successfully targets and binds to a broad spectrum of nerve agents, including sarin and tabun, which are believed to be part of the Syrian chemical weapons inventory.
News For PIP From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
April 13, 2015
08:11 EDTPIPPharmAthene receives $5.8M payment from BARDA
PharmAthene announced that on April 9 it received from the Biomedical Advanced Research and Development Authority, or BARDA, a one-time payment of $5.8M related to the reconciliation between the actual and the provisional rates on the performance of the SparVax contract for the years 2008 through 2013 for actual costs incurred during that period. The contract ended on February 28

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use